Device recall
Z-0113-04: Amvisc Intraocular Injection Sodium hyaluronate 12 mg/ml For European…
FDA device recall · Class III · Anika Therapeutics
Key facts
| Recall number (Z-number) | Z-0113-04 |
|---|---|
| Recall event | 27457 |
| Product | Amvisc Intraocular Injection Sodium hyaluronate 12 mg/ml For European Distribution Manufactured for Bausch & Lomb Surgical,Irvine,CA and |
| Product code | LZP |
| Recalling firm | Anika Therapeutics |
| Recall class | Class III |
| Status | Terminated |
| Termination date | Aug 9, 2004 |
| PMA numbers | P810025 |
| FEI number | 3007093114 |
At a glance
- None Linked 510(k)s
- 1–9 Products in the same recall event
- 10–99 Recalled products with this product code
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device recalls (products)
Each recalled device product receives a Z-number. Recall details such as root cause, distribution and firm actions are available in Orca1.
Source: U.S. Food and Drug Administration (FDA), Medical Device Recalls database